Taking the Next Step in Double Refractory Disease: Current and Future Treatment Strategies for Chronic Lymphocytic Leukemia.

Authors:
Hayama M; Riches JC.

Journal:
Onco Targets Ther

Publication Year: 2024

DOI:
10.2147/OTT.S443924

PMCID:
PMC10929554

PMID:
38476308

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Onco Targets Ther

Detailed journal information not available.

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

2/6

33.3% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Disclosure MH is a former employee of AstraZeneca. JCR reports speakers’ fees from Janssen and expenses from NURIX. The authors report no other conflicts of interest in this work."

Funding Disclosure

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025